期刊文献+

胃癌术后放疗方式对肾脏剂量学影响的比较研究 被引量:9

Comparative research of the effect about the renal dosimetry with different radiotherapy after resection of gastric carcinoma
原文传递
导出
摘要 目的:比较胃癌术后三维适形放疗(3D-CRT)与调强适形放疗(IMRT)对肾脏剂量学的分布影响。方法:选择9例根治术后的进展期胃癌患者,应用Pinnacal三维计划系统(TPS)分别为每例患者设计4野3D-CRT和5、7野IMRT,所有计划给予处方剂量95%的计划靶体积(PTV)>45Gy;IMRT同时要求99%的PTV体积>42.75Gy。应用等剂量曲线及剂量体积直方图(DVH)比较各个计划之间靶区剂量的分布和肾脏的剂量受量差异。结果:4野3D-CRT和5、7野IMRT的靶区V45分别为0.96±0.03、0.95±0.02和0.95±0.02。所有计划靶区均满足处方剂量,与4野3D-CRT相比,IMRT明显提高靶区的剂量的均匀性(HI)和适形度(CI),并且降低双侧肾脏18Gy的剂量体积百分比(V18),但在低剂量(10Gy)体积百分比(V10)3种放射方式之间差异无统计学意义,P>0.05。5和7野IMRT之间不论在靶区剂量分布还是危及器官的剂量受量上均差异无统计学意义,P>0.05。结论:与3D-CRT比较,IMRT明显提高靶区均匀性,降低肾脏剂量受量和剂量体积百分比,但在V10上3种计划间差异无统计学意义。 OBJECTIVE: Dose distribution of kidney with intensity-modulated radiotherapy(IMRT),Three-dimensional conformal radiotherapy(3D-CRT) was compared after resection of advanced gastric carcinoma.METHODS: Nine patients who had undergone curatively resected gastic cancer treatment were enrolled for this research.For each patient,four-field 3D-CRT、five-and seven-field IMRT were designed with a prescibed dose of 45 Gy to at least 95% of plan target volume(PTV) by Pinnacal Three-dimensional plan system(TPS),The IMRT plan was required with a prescibed dose of 42.75 Gy at least 99% of PTV at the same time.Dose distribution of PTVs and kidney were compared by using Isodose curves and Dose-volume histograms(DVH).RESULTS:The results of the percentage of volume receiving 45 Gy by PTVs with four field 3D-CRT,five field IMRT and seven field IMRT are 0.96±0.03,0.95±0.02 and 0.95±0.02 respectively.All plans accord with the prescibed dose.The dose distribution of PTVs were comparable,Where IMRT plans achieved better conformity index(HI) and dose uniformity(CI) compared to the 3D-CRT plans.The percentage of volume receiving 18 Gy by bilateral kidney reduced significantly with IMRT plans,Howere as to the percentage of volume receiving lower dose 10 Gy(V10),there was no discrepancy(P0.05).There was no significantly statistical difference of dose distribution of PTVs and organs at risk(OARs) between 5-and 7-field IMRT(P0.05).CONCLUSION: Compared with 3D-CRT,a better target dose distribution and significant dose reduction to kidney could be achieved with the IMRT plans.But as to V10,there was no discrepancy between IMRT and 3D-CRT.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2012年第4期303-306,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 安徽省科技攻关项目(08010302190)
关键词 胃肿瘤 肾脏 三维适形放疗 调强适形放疗 stomach neoplasms renal three-dimensional conformal radiotherapy intensity-modulated radiation therapy
  • 相关文献

参考文献15

  • 1杨子鑫,刘巍.晚期胃癌内科治疗的研究进展[J].中华肿瘤防治杂志,2011,18(19):1572-1576. 被引量:26
  • 2Macdonald JS,Smalley SR,Benedetti J,et al.Chemoradiofhera-py after surgery compared with surgery alone for adenocarcinomaof the stomach or gastroesophageal junction[J].N Engl J Med,2001,345(10):725-730.
  • 3McCloskey SA,Yang GY.Benefits and challenges of radiationtherapy in gastric cancer:techniques for improving outcomes[J].Gastrointest Cancer Res,2009,3(1):15-19.
  • 4罗文广,张红雁,赵于飞,汪琳.胃癌术后同步放化疗的临床观察[J].中华肿瘤防治杂志,2009,16(21):1704-1706. 被引量:9
  • 5Marks LB,Yorke ED,Jackson A,et al.Use of normal tissuecomplication probability models in the clinic[J].Int J Radiat On-col Biol Phys,2010,76(3):S10-19.
  • 6Murthy K,Shukeili K,Kumar S,et al.Evaluation of dose cov-erage to target volume and normal tissue sparing in the adjuvantradiotherapy of gastric cancers:3D-CRT compared with dynamicIMRT[J].Biomed Imaging Interv J,2010,6(3):e29.
  • 7邓清华,李浦,闫风琴,刘鹏,卢珂,汤忠祝,马胜林,朱远.局部进展期胃癌术后调强放疗的剂量学研究[J].中华肿瘤防治杂志,2011,18(9):713-715. 被引量:3
  • 8Minn AY,Hsu A,La T,et al.Comparison of intensity-modula-ted radiotherapy and 3-dimensional conformal radiotherapy as ad-juvant therapy for gastric cancer[J].Cancer,2010,116(16):3943-3952.
  • 9Beauvois S,Van Houtte P.Late effects of radiations on the kid-ney[J].Cancer Radiother,1997,1(6):760-763.
  • 10Dawson LA,Kavanagh BD,Paulino AC,et al.Radiation-associ-ated kidney injury[J].Int J Radiat Oncol Biol Phys,2010,76(3):S108-115.

二级参考文献23

  • 1张瑜,潘建基,郑茁,柏朋刚,徐鹭英,林少俊.鼻咽癌调强适形放疗复发病例分析[J].中华肿瘤防治杂志,2007,14(13):1011-1013. 被引量:1
  • 2Cox J D, Stetz J, Paiak T F. Toxcity criteria of the Radiation Therapy Oneology Group(RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phs, 1995, 31(5) : 1341-1346.
  • 3Janunger K G, Hafstrom L,Glimelius B. Chemotherapy in gastric cancer: a review and updated meta analysis[J]. Ear J Surg, 2002,168(11) :597-608.
  • 4Valentini V,Cellini F, D'Angelillo R M. Combined treatments in gastric cancer:radiotherapy[J]. Suppl Tumori,2003,2(5):39- 44.
  • 5Macdonald J S, Smalley S R, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma ofthestomachorgastroesophagealjunction[J]. N Engl J Med,2001,345(10):725-730.
  • 6Sung Kinm, Do Hoon Lim. An Observational Study Suggesting Clinical Benefit For Adjuvant postoprerative Chemoradiation In a Population of Over 500 Cases After gastric Resection with D2 Nodal Dissection for Adenocarcinoma of the Stomach[J]. Int J Radiation Oncology Biol Phys, 2005,63(5):1279-1285.
  • 7Macdonald J S, Smalley S R, Benedetti J, et al. Chemoradio- therapy after surgery compared with surgery alone for adenocar- cinoma of the stomach or gastroesophageal junction[J]. N Engl J Med, 2001, 345(10):725-730.
  • 8Coburn N G, Guller U, Baxter N N, et al. Adjuvant therapy for resected gastric cancer-rapid, yet incomplete adoption following results of intergroup 0116 trial [J]. Int J Radiat Oncol Biol Phys, 2008, 70(4) :1073-1080.
  • 9Ajani J, D'Amico T A, Hayman J A, et al. Gastric cancer. Clin- ical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2003,1(1):28-39.
  • 10Matzinger O, Gerber E, Bernstein Z, et al. EORTC-ROG ex- pert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophage- al junction and the stomach[J]. Radiother Oneol, 2009, 92(2) : 164-175.

共引文献34

同被引文献57

  • 1陈旭明,姚升宇,许奕,徐冰,赵国旗.非共面野在脑胶质瘤调强放射治疗中的剂量学优势[J].中国医学物理学杂志,2011,28(2):2475-2477. 被引量:14
  • 2Bao-min Zheng,Xiao-xia Dong,Hao Wu,You-jia Duan,Shu-kui Han,Yan Sun.Dosimetry Comparison between Volumetric Modulated Arc Therapy with RapidArc and Fixed Field Dynamic IMRT for Local-Regionally Advanced Nasopharyngeal Carcinoma[J].Chinese Journal of Cancer Research,2011,23(4):259-264. 被引量:7
  • 3徐惠绵,徐岩.局部进展期胃癌外科治疗策略的共识与争议[J].消化肿瘤杂志(电子版),2012,4(3):139-141. 被引量:3
  • 4胡伟刚,章真,徐志勇,顾卫列,陆惠忠,何少琴.三维适形与调强放疗技术在胃癌术后放疗中的剂量学比较[J].中华放射肿瘤学杂志,2007,16(4):273-276. 被引量:35
  • 5赫捷,陈万青.2012中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:12-25.
  • 6Songun I, Putter H, Kranenbarg EM, et al. Surgical treat- ment of gastic cancer: 15 - year follow-up results of the randomised nationwide Dutch DiD2trial [ J]. Lancet On- col,2010,11 (5) :439-449.
  • 7Macdonald JS, Smalley SR, Benedetti J, et al. Chemora- diofherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junc- tion[J]. N Engl J Med,2001,345(10) :725-730.
  • 8Stephen R. Smalley, Jacqueline K, et al. Updated analysis of SWOG-Directed intergroup study 0116 :A Phase III tri- M of adjuvant radiochemotherapy versus observation after curative gastric cancer resection [ J ]. Journal of Clinical Oncology,2012,30 (19) :2327-2333.
  • 9Kim S, Lim DH, Lee J, et al. An observational study sug- gesting clinical benefit for adjuant postoperative cheoradi- ation in a population of over 500 cases after gastie resec- tion with D2 nodal dissection for adenocarcinoma of the stomach[ J ]. Int J Radiat Oneol Biol Phys ,2005,63 (5 : 1279-1285.
  • 10Lee J, Lira do H, Kim S, et al. Phase III trial companng capecitabine plus cisplatin versus capecitabine plus cispl- atin with concurrent capeeitabine radiotherapy in com- pletely resected gastric cancer with D2 lymph node dis- section : the ARTIST trial [ J ]. J Clin Oneol, 2012,30 ( 3 ) : 268-273.

引证文献9

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部